Australian researchers have achieved the most promising advance in brain cancer treatment in two decades, with a new clinical trial showing that a targeted drug can shrink previously incurable tumours by up to 90 per cent. As reported by Natasha Robinson in The...
Bioplatforms Australia, Australian BioCommons, and the European Molecular Biology Laboratory (EMBL) are deepening their long-standing collaboration in life science research, focusing on biological data, bioinformatics, and the growing role of artificial intelligence...
Key Points 1. The aim of this Voucher Scheme is to enable projects addressing significant scientific challenges using synthetic biology capabilities at NCRIS SynBio and NCRIS Partner facilities. 2. Applications for a Primary Voucher will include a Lead Provider from...
Therapeutic Innovation Australia (TIA), in partnership with Phenomics Australia, Bioplatforms Australia and ANSTO’s National Deuteration Facility, is thrilled to announce the successful recipients of the Pipeline Accelerator 2024-25 (Round 2). ...
Bioplatforms Australia congratulates Professor Peter Hoffmann from the University of South Australia on receiving the 2025 Australian Council of Graduate Research (ACGR) Award for Excellence in Industry Engagement. Professor Hoffmann, a long-standing collaborator of...
The Solutions for Manufacturing Advanced Regenerative Therapies (SMART CRC) has secured $65 million in federal government funding, launching a $238 million national initiative to revolutionise the manufacturing and delivery of life-changing therapies. Bioplatforms...
